Safety and quality of life of CDK4/6 inhibitors therapy for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: a multicenter cross-sectional survey in China
CDK4/6抑制剂治疗激素受体阳性、人表皮生长因子受体2阴性晚期乳腺癌的安全性和生活质量：一项中国多中心横断面调查
期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14223-8
Yang, Benlong; Sun, Zhengkui; Ouyang, Quchang; Tong, Zhongsheng; Wang, Shu; Li, Hongyuan; Niu, Zhaofeng; Chen, Yiding; Ma, Lin-Xiaoxi; Wang, Haoqi; Tang, Mu; Hu, Zheyu; Gao, Xueqiang; Wang, Xu; Xie, Fei; Cheng, Qiao; Shen, Yong; Geng, Cuizhi; Wang, Haibo; Wu, Jiong
